semaglutide compounding pharmacy denver Compounded FDA issues warning about some

All the Risks of Prescription GLP-1s May Not Be Known A major study published in 2017 found that nearly 1 out of every 3 drugs approved by the Food and Drug Administration (FDA) have a new safety issues detected in the years after approval. To think we know all the side effects of synthetic GLP-1s right now would be unwise

Saxenda is FDA-approved for chronic weight management, while Ozempic is used for Type 2 diabetes in adults

Real-world effectiveness of GLP-1 receptor agonists in clinical practice

The question of whether it is safe to take cannot yet be definitively answered and until full Phase 3 data are available and regulatory approval is granted, the safest course of action is to pursue treatment through established, approved pathways under the guidance of a qualified healthcare professional